If you liked this article you might like

Biotech Movers: Shire Falls on Stem Cell Program Transfer; Calithera, Synergy Up on FDA Approvals
Desire to Add Exposure Leads Indices Higher
The Best Timeframe Right Now Is the Intraday Trade
Shark Bites: Even Without Health Care Vote, Market's Feeling Better